GB0615327D0 - Culture medium containing kinase inhibitors and uses thereof - Google Patents

Culture medium containing kinase inhibitors and uses thereof

Info

Publication number
GB0615327D0
GB0615327D0 GBGB0615327.4A GB0615327A GB0615327D0 GB 0615327 D0 GB0615327 D0 GB 0615327D0 GB 0615327 A GB0615327 A GB 0615327A GB 0615327 D0 GB0615327 D0 GB 0615327D0
Authority
GB
United Kingdom
Prior art keywords
culture medium
medium containing
kinase inhibitors
containing kinase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0615327.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0606392.9A external-priority patent/GB0606392D0/en
Priority to GBGB0615327.4A priority Critical patent/GB0615327D0/en
Application filed by University of Edinburgh filed Critical University of Edinburgh
Publication of GB0615327D0 publication Critical patent/GB0615327D0/en
Priority to GBGB0700479.9A priority patent/GB0700479D0/en
Priority to US11/694,351 priority patent/US9074180B2/en
Priority to AU2007232393A priority patent/AU2007232393A1/en
Priority to GB0706239A priority patent/GB2436737B/en
Priority to EP07732217A priority patent/EP1999249B8/en
Priority to CA002645170A priority patent/CA2645170A1/en
Priority to AT07732217T priority patent/ATE530637T1/de
Priority to PCT/GB2007/001163 priority patent/WO2007113505A2/en
Priority to JP2009502219A priority patent/JP5680850B2/ja
Priority to EP11182239A priority patent/EP2457995A1/en
Priority to TW096111227A priority patent/TW200815597A/zh
Priority to GB0716426A priority patent/GB2451523B/en
Priority to AU2007280216A priority patent/AU2007280216B2/en
Priority to EP07766403A priority patent/EP2049654A2/en
Priority to CN201410720584.XA priority patent/CN104531610A/zh
Priority to CN200780036720.1A priority patent/CN101657535B/zh
Priority to JP2009522328A priority patent/JP5456467B2/ja
Priority to US11/832,317 priority patent/US8431395B2/en
Priority to PCT/GB2007/002913 priority patent/WO2008015418A2/en
Priority to IL193495A priority patent/IL193495A0/en
Priority to US12/581,981 priority patent/US20100041137A1/en
Priority to JP2013011454A priority patent/JP5728036B2/ja
Priority to US13/857,449 priority patent/US20130333058A1/en
Priority to JP2013127052A priority patent/JP2013176400A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0273—Cloned vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/103—Ovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0615327.4A 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof Ceased GB0615327D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB0615327.4A GB0615327D0 (en) 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof
GBGB0700479.9A GB0700479D0 (en) 2006-08-01 2007-01-10 Culture medium containing kinase inhibitors, and uses thereof
TW096111227A TW200815597A (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors, and uses thereof
EP11182239A EP2457995A1 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors, and uses thereof
AU2007232393A AU2007232393A1 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors. and uses thereof
US11/694,351 US9074180B2 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors, and uses thereof
GB0706239A GB2436737B (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors,and uses thereof
EP07732217A EP1999249B8 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors. and uses thereof
CA002645170A CA2645170A1 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors, and uses thereof
AT07732217T ATE530637T1 (de) 2006-03-30 2007-03-30 Kulturmedium mit kinasehemmern und verwendung
PCT/GB2007/001163 WO2007113505A2 (en) 2006-03-30 2007-03-30 Culture medium containing kinase inhibitors. and uses thereof
JP2009502219A JP5680850B2 (ja) 2006-03-30 2007-03-30 キナーゼインヒビターを含む培養培地およびその使用
PCT/GB2007/002913 WO2008015418A2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species
GB0716426A GB2451523B (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species
AU2007280216A AU2007280216B2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species
US11/832,317 US8431395B2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species
EP07766403A EP2049654A2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species
CN201410720584.XA CN104531610A (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞
CN200780036720.1A CN101657535B (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞
JP2009522328A JP5456467B2 (ja) 2006-08-01 2007-08-01 ラットおよび他種由来の多能性細胞
IL193495A IL193495A0 (en) 2006-03-30 2008-08-17 Culture medium containing kinase inhibitors and uses thereof
US12/581,981 US20100041137A1 (en) 2006-03-30 2009-10-20 Culture medium containing kinase inhibitors, and uses thereof
JP2013011454A JP5728036B2 (ja) 2006-03-30 2013-01-24 キナーゼインヒビターを含む培養培地およびその使用
US13/857,449 US20130333058A1 (en) 2006-08-01 2013-04-05 Pluripotent Cells From Rat and Other Species
JP2013127052A JP2013176400A (ja) 2006-08-01 2013-06-17 ラットおよび他種由来の多能性細胞

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0606392.9A GB0606392D0 (en) 2006-03-30 2006-03-30 Culture medium containing kinase inhibitors, and uses thereof
GBGB0615327.4A GB0615327D0 (en) 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
GB0615327D0 true GB0615327D0 (en) 2006-09-13

Family

ID=37809760

Family Applications (3)

Application Number Title Priority Date Filing Date
GBGB0615327.4A Ceased GB0615327D0 (en) 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof
GBGB0700479.9A Ceased GB0700479D0 (en) 2006-08-01 2007-01-10 Culture medium containing kinase inhibitors, and uses thereof
GB0716426A Expired - Fee Related GB2451523B (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species

Family Applications After (2)

Application Number Title Priority Date Filing Date
GBGB0700479.9A Ceased GB0700479D0 (en) 2006-08-01 2007-01-10 Culture medium containing kinase inhibitors, and uses thereof
GB0716426A Expired - Fee Related GB2451523B (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species

Country Status (7)

Country Link
US (2) US8431395B2 (cg-RX-API-DMAC7.html)
EP (1) EP2049654A2 (cg-RX-API-DMAC7.html)
JP (2) JP5456467B2 (cg-RX-API-DMAC7.html)
CN (2) CN101657535B (cg-RX-API-DMAC7.html)
AU (1) AU2007280216B2 (cg-RX-API-DMAC7.html)
GB (3) GB0615327D0 (cg-RX-API-DMAC7.html)
WO (1) WO2008015418A2 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
US8357666B2 (en) * 2005-08-01 2013-01-22 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through RNA interference
EP1999249B8 (en) * 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
MX352541B (es) 2007-04-07 2017-11-29 Whitehead Inst Biomedical Res Reprogramación de células somáticas.
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CN101918541A (zh) * 2007-07-18 2010-12-15 塞拉提斯股份公司 衍生自hBS细胞的心肌细胞样细胞簇
CA2695225C (en) 2007-07-31 2021-06-01 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
WO2009032194A1 (en) 2007-08-31 2009-03-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
CA2718904C (en) 2008-03-17 2017-01-03 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
AU2009233845A1 (en) * 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
CA2969377C (en) 2008-06-13 2019-12-03 Whitehead Institute For Biomedical Research Programming and reprogramming of cells
EP2942392B1 (en) 2008-06-30 2018-10-03 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
EP2369916A4 (en) * 2008-12-01 2013-04-10 Univ Texas PREPARATION AND USE OF SPERMATOGONIAL STEM CELL LINES FROM THE RAT
ES2645869T3 (es) 2008-12-17 2017-12-11 The Scripps Research Institute Generación y mantenimiento de células madre
EP2421956A4 (en) * 2009-04-24 2013-10-02 Whitehead Biomedical Inst COMPOSITIONS AND METHODS FOR OBTAINING OR CULTURING PLURIPOTENTER CELLS
JP5808331B2 (ja) * 2009-10-16 2015-11-10 ザ スクリプス リサーチ インスティテュート 多能性細胞の誘導法
EP2508595B1 (en) 2009-12-01 2016-11-23 National Cancer Center Method for constructing chimeric rat using rat embryonic stem cells
EP2505639B1 (en) * 2009-12-29 2018-09-19 Takeda Pharmaceutical Company Limited Method for manufacturing pancreatic-hormone-producing cells
ES2624780T3 (es) 2010-03-31 2017-07-17 The Scripps Research Institute Reprogramación de células
US20130059375A1 (en) * 2010-04-02 2013-03-07 Riken Method for preparing es cells
ES2685171T3 (es) 2010-06-14 2018-10-05 The Scripps Research Institute Reprogramación de células a un nuevo destino
CN102344490B (zh) * 2010-07-30 2014-03-05 中国科学院上海生命科学研究院 抗小鼠Stk40的多克隆抗体及其制备
NZ607608A (en) * 2010-08-09 2014-03-28 Takeda Pharmaceuticals Co Method of producing pancreatic hormone-producing cells
JP6090855B2 (ja) * 2010-11-17 2017-03-08 国立大学法人京都大学 心筋細胞および／または心筋前駆細胞増殖剤ならびに心筋細胞および／または心筋前駆細胞の増殖方法
KR101975688B1 (ko) 2010-12-22 2019-05-07 페이트 세러퓨틱스, 인코포레이티드 단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
US20140127133A1 (en) * 2011-01-24 2014-05-08 Claude Brodski Method for evaluating a mental disorder
US20140234963A1 (en) 2011-06-21 2014-08-21 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
SI3865581T1 (sl) 2011-08-05 2024-12-31 Regeneron Pharmaceuticals, Inc. Miši s humanizirano univerzalno lahko verigo
PL2793567T3 (pl) * 2011-12-20 2019-09-30 Regeneron Pharmaceuticals, Inc. Myszy z humanizowanym łańcuchem lekkim
PT2847335T (pt) 2012-04-25 2018-09-28 Regeneron Pharma Alvejamento mediado por nuclease com vetores de alvejamento grandes
EP3561050B1 (en) 2013-02-20 2021-12-08 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
HUE040575T2 (hu) * 2013-04-16 2019-03-28 Regeneron Pharma A patkány genom célzott módosítása
WO2014197934A1 (en) 2013-06-14 2014-12-18 The University Of Queensland Renal progenitor cells
US9546384B2 (en) 2013-12-11 2017-01-17 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a mouse genome
KR102670874B1 (ko) 2014-03-04 2024-05-31 페이트 세러퓨틱스, 인코포레이티드 개선된 재프로그래밍 방법 및 세포 배양 플랫폼
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
JP6652334B2 (ja) 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
LT3152312T (lt) 2014-06-06 2020-04-27 Regeneron Pharmaceuticals, Inc. Tikslinio lokuso modifikavimo būdai ir kompozicijos
EP3461885B1 (en) 2014-06-26 2021-10-20 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
HUE044907T2 (hu) 2014-11-21 2019-11-28 Regeneron Pharma Módszerek és készítmények célzott genetikai módosításhoz, párosított mutató RNS-ek használatával
NZ732895A (en) 2014-12-19 2022-05-27 Regeneron Pharma Methods and compositions for targeted genetic modification through single-step multiple targeting
SG11201707858TA (en) * 2015-03-30 2017-10-30 Ajinomoto Kk Human serum albumin-containing culture medium for growth of neural stem cells
EP3362570A4 (en) 2015-10-16 2019-03-20 Fate Therapeutics, Inc. PLATFORM FOR THE INDUCTION AND MAINTENANCE OF BASIC STATUS PLURIPOTENCE
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
DK3519558T3 (da) 2016-09-28 2023-11-13 Organovo Inc Anvendelse af modificeret nyrevæv i assays
WO2019208787A1 (ja) * 2018-04-27 2019-10-31 株式会社カネカ 原始腸管細胞の製造方法
CN113316634A (zh) * 2018-11-21 2021-08-27 新加坡科技研究局 成熟的库普弗细胞的产生
CN111238897B (zh) * 2020-02-18 2023-03-28 上海市皮肤病医院 生物标本的处理方法与处理剂
JP2023532061A (ja) * 2020-07-02 2023-07-26 アクセルタ リミテッド 遅延胚由来の哺乳類家畜多能性幹細胞
EP4386082A4 (en) * 2021-08-10 2025-08-20 Kaneka Corp PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS
CN115927166A (zh) * 2022-12-06 2023-04-07 云南省第一人民医院 一种大鼠原始内胚层干细胞分离建系的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AU7677894A (en) 1993-08-30 1995-03-22 Northwestern University Rat pluripotent embryonic stem cells and method of obtaining and using same
CA2267220A1 (en) 1996-10-11 1998-04-23 The Texas A & M University System Methods for the generation of primordial germ cells and transgenic animal species
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
WO1998030679A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
WO1999027076A1 (en) 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
GB9819912D0 (en) 1998-09-11 1998-11-04 Univ Edinburgh Propagation and/or derivation of embryonic stem cells
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
US20020045260A1 (en) 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
JP2002176973A (ja) 2000-12-14 2002-06-25 Shigeo Saito 哺乳動物胚性幹細胞とその樹立方法並びにその継代培養方法
AU2003210405A1 (en) 2002-03-05 2003-09-16 Artemis Pharmaceuticals Gmbh Inbred embryonic stem-cell derived mice
GB0210539D0 (en) 2002-05-08 2002-06-19 Univ Edinburgh Control of es cell self renewal and lineage specification, and medium therefor
US7338957B2 (en) 2003-08-28 2008-03-04 Irm Llc Compounds and compositions as protein kinase inhibitors
SG149061A1 (en) * 2003-12-23 2009-01-29 Cythera Inc Definitive endoderm
US8137966B2 (en) 2004-03-04 2012-03-20 Dainippon Sumitomo Pharma Co., Ltd. Rat embryonic stem cell
WO2005094830A1 (en) 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
WO2006026473A2 (en) 2004-08-25 2006-03-09 University Of Georgia Research Foundation, Inc. METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
CN101238129A (zh) 2005-06-10 2008-08-06 Irm责任有限公司 维持胚胎干细胞多能性的化合物
JP2009517085A (ja) 2005-11-28 2009-04-30 チョンウェ ファーマ コーポレイション 培養における細胞の無血清増殖
EP1999249B8 (en) 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
WO2007113705A1 (en) * 2006-04-03 2007-10-11 Koninklijke Philips Electronics N. V. Determining tissue surrounding an object being inserted into a patient
EP2018167A4 (en) 2006-05-15 2010-07-14 Irm Llc COMPOSITIONS AND METHODS AS INHIBITORS OF FGF RECEPTOR KINASES

Also Published As

Publication number Publication date
AU2007280216A1 (en) 2008-02-07
WO2008015418A3 (en) 2008-04-10
GB0716426D0 (en) 2007-10-10
GB2451523A8 (en) 2009-02-18
JP2013176400A (ja) 2013-09-09
WO2008015418A2 (en) 2008-02-07
CN101657535B (zh) 2016-03-02
CN104531610A (zh) 2015-04-22
US20130333058A1 (en) 2013-12-12
JP2009545302A (ja) 2009-12-24
GB2451523A (en) 2009-02-04
AU2007280216B2 (en) 2012-12-20
GB0700479D0 (en) 2007-02-21
EP2049654A2 (en) 2009-04-22
CN101657535A (zh) 2010-02-24
US20080066197A1 (en) 2008-03-13
GB2451523B (en) 2010-03-17
JP5456467B2 (ja) 2014-03-26
US8431395B2 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
GB0700479D0 (en) Culture medium containing kinase inhibitors, and uses thereof
WO2007113505A3 (en) Culture medium containing kinase inhibitors. and uses thereof
WO2010008486A3 (en) Pluripotent cell lines and methods of use thereof
MX2008013582A (es) Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.
MY153727A (en) Pyridazinone derivatives
PL2094107T3 (pl) Kompozycja redukująca zawartość mikotoksyny
EP2497470B8 (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
EP3153023B8 (en) Benzoxazole kinase inhibitors and methods of use
UA99311C2 (en) Inhibitors of c-fms kinase
WO2012065067A3 (en) Immortalization of epithelial cells and methods of use
MX2009012708A (es) Derivados de piridazinona.
AU2017263716A1 (en) Haematopoietic stem/progenitor cells
EP1981888A4 (en) TYROSINE KINASE INHIBITORS AND USES THEREOF
ATE530636T1 (de) Zellkultur
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
JO2985B1 (ar) مثبطات كينازmapk/erk
TN2011000207A1 (en) Akt and p70 s6 kinase inhibitors
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.
IL217321A0 (en) Novel (6-oxo-1,6 - dihydro - pyrimidin - 2 - yl) - amide derivatives, prepartion thereof, and pharamaceutical use thereof as akt (pkb) phosphorylation inhibitors
MX2008009830A (es) Efecto del inhibidor bst2.
MX2009008122A (es) Composiciones farmaceuticas y metodos para utilizar temozolomida e inhibidores de quinasa multidirigidos.
WO2007084949A3 (en) Modulators of cardiac cell hypertrophy and hyperplasia
WO2007109067A3 (en) Non-random aptamer libraries and methods for making
AU316238S (en) Lawning applicator for microbiological cultures
SG151171A1 (en) Association between an anti-atherothrombotic and an angiotensin- converting enzyme inhibitor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)